Venous thromboembolism (VTE)

Award for new blood clot prevention technology

A partnership between the Royal Stoke University Hospital, part of the University Hospitals of North Midlands NHS Trust, and a UK industry-leading medical devices company have been rewarded for its use of an innovative bioelectronic technology to prevent life-threatening blood clots in acute stroke patients – winning in the category: Best use of technology (acute care), at the Building Better Healthcare Awards.

The collaboration, a partnership between the Royal Stoke and UK-based Sky Medical Technology (Sky), investigated though a prospective study of two care pathways, the  use of the company's geko device in preventing venous thromboembolism (VTE), blood clots, in high-risk patients at the hospital's leading Stroke Unit.

VTE is a major risk to hospitalised patients, with an estimated 40,000 deaths in England annually, 62 per cent of which are preventable given proper management – with acute stroke patients being a high at-risk population due to reduced mobility. The geko device (approved by NICE), is the size of a wristwatch and worn at the knee. The daily disposable device gently stimulates the common peroneal nerve activating the calf and foot muscle pumps, resulting in increased blood flow in the deep veins of the calf.

Photo

The comparative study assessed 1,000 acute stroke patients for VTE incidence at 90 days post discharge and reported 0% VTE in patients wearing the geko device alone, along with good patient tolerance, compared to VTE in patients prescribed intermittent pneumatic compression devices (IPC) at 2.4% or pharmacological prophylaxis at 0.8%.

The investigators, led by Mr. Indira Natarajan, consultant stroke physician and clinical director for neurosciences and Professor Christine Roffe, determined that 30% of patients are contraindicated or became intolerant to IPC (discomfort or dislike to IPC). It is to this unmet need cohort that the geko device was fitted, reporting a zero VTE incidence and good patient tolerance. Commenting on behalf of the Royal Stoke University Hospital, Mr Indira Natarajan said: "We are thrilled to win this award, and our thanks go to the Building Better Healthcare team for recognising our use of innovative technology to address this important unmet need. I would also like to thank Sky. The geko device marks a significant change to our nursing practice when other VTE prevention strategies are contraindicated or impractical, and provides an option where previously patients would have had no other intervention available to them."

Also commenting, Bernard Ross, CEO Sky Medical Technology said: "The 1,000 patient data set has not only changed clinical practice nationally – over 27 NHS Hospitals are actively working to embed the geko device within their acute stroke care pathways – the data also helped to secure FDA 510(k) clearance, making the geko the first device of its kind to be cleared for VTE prevention across all patients, including non-surgical patients in the USA. This tremendous success demonstrates the huge potential of industry and NHS partnering, and it is to the Royal Stoke team that we owe our sincere thanks. Without their commitment, passion and willingness to embrace innovation, none of this would be possible."


Source: University Hospitals of North Midlands NHS Trust

13.11.2019

Read all latest stories

Related articles

Photo

Blood thinning 2.0

Developing next generation anticoagulants

A University of Leeds spin-out company has secured £3.14m to develop a next generation drug that aims to prevent blood clots forming, without the risk of bleeding present in currently available…

Photo

Personalised prevention

‘Liquid health check’ could predict disease risk

Proteins in our blood could in future help provide a comprehensive ‘liquid health check’, assessing our health and predicting the likelihood that we will we will develop a range of diseases.…

Photo

Blood thinners

Experts' plea for anticoagulant dosage guidelines

Rutgers researchers have found a way to reduce bleeding in patients following bariatric surgery. The study, which appeared in the journal Surgery for Obesity and Related Disorders, was conducted by…

Related products

AB Medical – V-Tube EDTA K2, K3

Blood Cell Counter

AB Medical – V-Tube EDTA K2, K3

AB Medical V-Tube
Analyticon Biotechnologogies – Hemolyzer 3 NG / Hemolyzer 5 NG

Blood Cell Counter

Analyticon Biotechnologogies – Hemolyzer 3 NG / Hemolyzer 5 NG

Analyticon Biotechnologies AG
BD Vacutainer UltraTouch Push Button Blood Collection Set

Blood Collection

BD Vacutainer UltraTouch Push Button Blood Collection Set

BD – Becton Dickinson
Beckman Coulter – DxH 520 Hematology Analyzer

Blood Cell Counter

Beckman Coulter – DxH 520 Hematology Analyzer

Beckman Coulter, Inc.
Beckman Coulter – Early Sepsis Indicator

Blood Cell Counter

Beckman Coulter – Early Sepsis Indicator

Beckman Coulter, Inc.
Greiner – Vacuette EDTA Tube

Blood Cell Counter

Greiner – Vacuette EDTA Tube

Greiner Bio-One